BACKGROUND AND OBJECTIVES: High-dose chemotherapy followed by autologous stem
cell transplantation (HDT/ASCT) has proven to be superior to conventional chemotherapy in
patients with chemosensitive relapse of aggressive non-Hodgkin's lymphoma (NHL).
Therefore, HDT/ASCT was evaluated as part of first-line therapy. Several trials generated
conflicting results. This meta-analysis summarizes the available evidence from all suitable
studies. DESIGN AND METHODS: Prospective, randomized trials with HDT/ASCT as first …

Background and Objectives Several trials have generated conflicting results about the
results of high-dose chemotherapy followed by autologous stem cell transplantation (HDCT)
for primary breast cancer. This meta-analysis summarizes the available evidence from all
suitable studies. Design and Methods Prospective, randomized trials with HDCT as a first-
line therapy for primary breast cancer were included in this meta-analysis. The primary
outcome of interest for our analysis was survival (disease-free survival and overall survival); …